Dimensional Fund Advisors
PHAT icon

Dimensional Fund Advisors’s Phathom Pharmaceuticals PHAT Stock Holding History

Dimensional Fund Advisors’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-73,649
Closed -$1M – 3514
2022
Q1 		$1M Buy
73,649
+12,609
+21% +$204K ﹤0.01% 2994
2021
Q4 		$1.2M Buy
61,040
+21,666
+55% +$510K ﹤0.01% 2985
2021
Q3 		$1.26M Buy
+39,374
New +$1.31M ﹤0.01% 2990

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Dimensional Fund Advisors's PHAT Position: Q2 2022 in Review

Dimensional Fund Advisors sold out of Phathom Pharmaceuticals (PHAT) in Q2 2022, closing a stake of 73,649 shares — an estimated $1M sold.

Dimensional Fund Advisors first reported a position in PHAT in Q3 2021 and held it in 3 quarters. The position peaked at $1.26M in Q3 2021. 94 funds tracked by Wall St. Rank hold PHAT as of Q2 2022.

  • Dimensional Fund Advisors reported no remaining Phathom Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Dimensional Fund Advisors sold 73,649 Phathom Pharmaceuticals shares in Q2 2022, an estimated $1M.
  • Dimensional Fund Advisors first reported a position in Phathom Pharmaceuticals in Q3 2021 and held it in 3 quarters.
  • Dimensional Fund Advisors's Phathom Pharmaceuticals position peaked at $1.26M in Q3 2021.
  • 94 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2022.

Based on Dimensional Fund Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.